Efficacy and acceptability of needles 4 mm length in pediatric insulin therapy

Pediatric patients affected by type 1 diabetes teaching to use 4 mm length needles for insulin therapy compared with diabetic children using 8 mm length needles regarding metabolic control parameters and quality of life

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ANZCTR

Registry ID

ACTRN12612000554864

Enrollment

100

Registered

2012-05-24

Start date

2011-04-01

Completion date

Unknown

Last updated

2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Availability of new, short length, 4 mm needles for insulin therapy could improve compliance in children with type 1 diabetes; however, there are some concerns about insulin leakage and efficacy of these devices. We aim to test efficacy and assess satisfation of 4 mm length needles use in a population of children with newly diagnosed type 1 diabetes or previously undergoing insulin therapy four-time a day by 8-mm length needles

Interventions

Use of 4 mm length needles for insulin administration for a period of 12 months, in newly type1 diabetic children or shift to 4 mm needles in patients undergoing therapy by 8 mm length needles; because the dosage of insulin should be adjusted according to blood glucose values, all patients are required to perform blood glucose testing at least 4 times/day and to apply a provided therapy algorithm All patients and their parents will undergoing a 30 minutes instruction course, carried out by a tra

Study design

Allocation

Non-randomised trial

Primary purpose

Treatment

Masking

Open (masking not used)

Eligibility

Sex/Gender

All

Age

2 Years to 17 Years

Healthy volunteers

Inclusion criteria

type 1 diabetes

Exclusion criteria

coeliac disease, thyroiditis, psichiatryc impairment, coagulation disease; HbA1c > 9,5% (except time of diagnosis)

Outcome results